In particular, the function of insulin-producing β-cells is more severely impaired in most patients with type 1 diabetes mellitus than in patients with type 2 diabetes mellitus, and those with β-cell insufficiencies require an exogenous insulin replacement. The gene discussed is INS; the disease is type 2 diabetes mellitus.